Parad RB - Search Results

1

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.

Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB. Parad RB, et al. Infect Immun. 1999 Sep;67(9):4744-50. doi: 10.1128/IAI.67.9.4744-4750.1999. Infect Immun. 1999. PMID: 10456926 Free PMC article.

2

A sequence variation in intron 17B of the cystic fibrosis transmembrane conductance regulator gene.

Parad RB, Gerard C. Parad RB, et al. Hum Mutat. 1992;1(3):258-9. doi: 10.1002/humu.1380010313. Hum Mutat. 1992. PMID: 1284536 No abstract available.

3

Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D.

Parad RB. Parad RB. J Med Genet. 1996 Aug;33(8):711-3. doi: 10.1136/jmg.33.8.711. J Med Genet. 1996. PMID: 8863168 Free PMC article.

4

Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and neurophysiology.

McAnulty G, Duffy FH, Butler S, Parad R, Ringer S, Zurakowski D, Als H. McAnulty G, et al. Acta Paediatr. 2009 Dec;98(12):1920-6. doi: 10.1111/j.1651-2227.2009.01492.x. Epub 2009 Sep 7. Acta Paediatr. 2009. PMID: 19735497 Free PMC article. Clinical Trial.

5

Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement.

Parad RB. Parad RB. Pediatrics. 1998 May;101(5):851-5. doi: 10.1542/peds.101.5.851. Pediatrics. 1998. PMID: 9565413

6

Diagnosis of Cystic Fibrosis in Screened Populations.

Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA. Farrell PM, et al. Among authors: parad rb. J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065. J Pediatr. 2017. PMID: 28129810 Free article.

7

Newborn screening for cystic fibrosis.

Parad RB, Comeau AM. Parad RB, et al. Pediatr Ann. 2003 Aug;32(8):528-35. doi: 10.3928/0090-4481-20030801-10. Pediatr Ann. 2003. PMID: 12942895

8

NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction.

Als H, Duffy FH, McAnulty G, Butler SC, Lightbody L, Kosta S, Weisenfeld NI, Robertson R, Parad RB, Ringer SA, Blickman JG, Zurakowski D, Warfield SK. Als H, et al. Among authors: parad rb. J Perinatol. 2012 Oct;32(10):797-803. doi: 10.1038/jp.2011.201. Epub 2012 Feb 2. J Perinatol. 2012. PMID: 22301525 Free PMC article. Clinical Trial.

9

Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) effective for preterm infants with intrauterine growth restriction?

Als H, Duffy FH, McAnulty GB, Fischer CB, Kosta S, Butler SC, Parad RB, Blickman JG, Zurakowski D, Ringer SA. Als H, et al. Among authors: parad rb. J Perinatol. 2011 Feb;31(2):130-6. doi: 10.1038/jp.2010.81. Epub 2010 Jul 22. J Perinatol. 2011. PMID: 20651694 Free PMC article. Clinical Trial.

10

Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.

O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R. O'Sullivan BP, et al. Pediatrics. 2006 Sep;118(3):1260-5. doi: 10.1542/peds.2006-0399. Pediatrics. 2006. PMID: 16951024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters